Juncell Therapeutics
Jiading
About Juncell Therapeutics
Juncell Therapeutics develops innovative therapies and pharmaceutical drugs for tumor and related treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: juncell.com
- Phone: +86 216-911-0327
Industries & Categories
Biopharma, Manufacturing, Pharmaceutical
Canonical: https://fsome.com/organization/juncell-therapeutics-2794252 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.